• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates

tetano

Editor, Senior Moderator
PLoS One


. 2022 Sep 22;17(9):e0274961.
doi: 10.1371/journal.pone.0274961. eCollection 2022.
Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates


Mariane Daou[SUP] 1 [/SUP], Hussein Kannout[SUP] 2 [/SUP], Mariam Khalili[SUP] 2 [/SUP], Mohamed Almarei[SUP] 2 [/SUP], Mohamed Alhashami[SUP] 2 [/SUP], Zainab Alhalwachi[SUP] 2 [/SUP], Fatima Alshamsi[SUP] 2 3 [/SUP], Mohammad Tahseen Al Bataineh[SUP] 4 5 [/SUP], Mohd Azzam Kayasseh[SUP] 6 [/SUP], Abdulmajeed Al Khajeh[SUP] 7 [/SUP], Shadi W Hasan[SUP] 8 [/SUP], Guan K Tay[SUP] 2 9 10 [/SUP], Samuel F Feng[SUP] 2 11 [/SUP], Dymitr Ruta[SUP] 12 [/SUP], Ahmed F Yousef[SUP] 1 8 [/SUP], Habiba S Alsafar[SUP] 2 3 13 [/SUP], UAE COVID-19 Collaborative Partnership



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) was first identified in respiratory samples and was found to commonly cause cough and pneumonia. However, non-respiratory symptoms including gastrointestinal disorders are also present and a big proportion of patients test positive for the virus in stools for a prolonged period. In this cross-sectional study, we investigated viral load trends in stools and nasopharyngeal swabs and their correlation with multiple demographic and clinical factors. The study included 211 laboratory-confirmed cases suffering from a mild form of the disease and completing their isolation period at a non-hospital center in the United Arab Emirates. Demographic and clinical information was collected by standardized questionnaire and from the medical records of the patient. Of the 211 participants, 25% tested negative in both sample types at the time of this study and 53% of the remaining patients had detectable viral RNA in their stools. A positive fecal viral test was associated with male gender, diarrhea as a symptom, and hospitalization during infection. A positive correlation was also observed between a delayed onset of symptoms and a positive stool test. Viral load in stools positively correlated with, being overweight, exercising, taking antibiotics in the last 3 months and blood type O. The viral load in nasopharyngeal swabs, on the other hand, was higher for blood type A, and rhesus positive (Rh factor). Regression analysis showed no correlation between the viral loads measured in stool and nasopharyngeal samples in any given patient. The results of this work highlight the factors associated with a higher viral count in each sample. It also shows the importance of stool sample analysis for the follow-up and diagnosis of recovering COVID-19 patients.
 
Back
Top Bottom